Select Language: EN
Welcome to our store!
 



5-LOXIN® Boswellia Serrata Extract

5-LOXIN® Boswellia Serrata Extract
Share this Page:
Item: SWU770

• The power of the boswellia serrata herb in support of health
• A patented formula guaranteeing the supply of all benefits of the herb
• Provides 30% acetyl-keto-beta-boswellic acid (AKBA) for effective and reliable results

Send to friend
125 mg 60 Veg Caps
21.02€
Quantity
  • Detailed Description

Boswellia serrata is one of the most extensively studied and acknowledged herbs with a wide range of health benefits. But similar to many other herbal supplements, the natural changes in the content can hinder their effectiveness. 5-Loxin® is a patented formula of standardised boswellia extract, which solves this problem and guarantees the respective amount of the main active ingredient in every vegetable capsule. Scientists know that boswellic acid is responsible for the benefits of boswellia and many supplements provide standardised levels. Nevertheless, of six boswellic acids only one is most active. This fraction, called AKBA, is present in just 2-3% in most extracts. 5-Loxin is the only supplement with boswellia which provides 30% of AKBA for truly good reliable results. Clinical trials have confirmed 5-Loxin’s safety and it has been proven that results show in just 7 days. You can surely find 5-Loxin in some of the other popular boswellia supplements but at a very high price. Why pay so much? With Swanson Health Products you can get the same benefits for much less money. Other ingredients: brown rice flour, hypromellose (vegetable capsule), may contain one or more of the following: magnesium stearate, silica. Recommended use: As a dietary supplement, take one vegetable capsule twice a day with food and water. 5-LOXIN® is a registered trademark of P.L. Thomas-Laila Nutra LLC and is used by licence.

Size: 125 mg 60 Veg Caps


LEAVE A COMMENT:

Your email address will not be published. Required fields are marked *




This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.   I agree